Status:

COMPLETED

An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack

Lead Sponsor:

ProEthic Pharmaceuticals

Conditions:

Migraine

Photophobia

Eligibility:

All Genders

18-65 years

Phase:

PHASE3

Brief Summary

The purpose of the study is to show the efficacy of a single dose of PRO-513 for treating subjects suffering moderate pain form a migraine attack, with or without aura. The study is also intended to s...

Eligibility Criteria

Inclusion

  • Male and Female subjects
  • 18-65 years of age
  • Primary diagnosis of migraine attack with aura or migraine attack without aura
  • Migraine history of averaging at least 1 migraine attack per month but averaging not more than 6 migraine attacks per month over the prior year
  • Female subjects must use an effective form of birth control
  • Listing of additional inclusion criteria are available through the Sponsor

Exclusion

  • Excluding subjects with a history of other serious events causing secondary headaches
  • Excluding subjects with a current medical condition that could interfere with the overall study intent or affect the absorption, distribution, metabolism, or excretion of the study medication
  • Excluding subjects with a history or current medical condition that could confound the study results or use of a concomitant medication that could interfere with the study drug
  • Listing of additional exclusion criteria are available through the Sponsor

Key Trial Info

Start Date :

May 1 2006

Trial Type :

INTERVENTIONAL

End Date :

December 1 2006

Estimated Enrollment :

650 Patients enrolled

Trial Details

Trial ID

NCT00330850

Start Date

May 1 2006

End Date

December 1 2006

Last Update

April 2 2007

Active Locations (16)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (16 locations)

1

Associated Neurologists of Southern CT

Fairfield, Connecticut, United States, 06824

2

New England Center for Headache

Stamford, Connecticut, United States, 06902

3

LCFP Inc.

Fort Myers, Florida, United States, 33907

4

Palm Beach Neurological Center

Palm Beach Gardens, Florida, United States, 33410

An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack | DecenTrialz